Editorial Commentary
Cancer of unknown primary in the neck—challenging in diagnosis and treatment
Translational Cancer Research
2026;
15
(5)
:360
.
(30 May 2026)
Induced pluripotent stem cell-derived natural killer cells: poised for the clinic as an off-the-shelf allogeneic cell therapy
Translational Cancer Research
2026;
15
(5)
:361
.
(30 May 2026)
Computed tomography monitoring of small lung nodules: finding the right balance
Translational Cancer Research
2026;
15
(5)
:362
.
(30 May 2026)
Antiviral therapy and the risk of extrahepatic malignancies in chronic hepatitis C: insights from recent evidence
Translational Cancer Research
2026;
15
(5)
:363
.
(30 May 2026)
Translation is not exportation: why European Prospective Investigation into Cancer and Nutrition rewrites the 4Kscore story
Translational Cancer Research
2026;
15
(5)
:364
.
(30 May 2026)
Fully human BCMA CAR-T therapy in multiple myeloma: lessons from long-term follow-up
Translational Cancer Research
2026;
15
(5)
:365
.
(30 May 2026)
Quality of life with EV-302 in advanced urothelial carcinoma: lessons and implications
Translational Cancer Research
2026;
15
(5)
:366
.
(30 May 2026)
Reconsidering dual BCR::ABL1 inhibition in Philadelphia chromosome-positive acute lymphoblastic leukemia: is sequential better than concurrent?
Translational Cancer Research
2026;
15
(5)
:367
.
(30 May 2026)
Defining the biological boundaries of daratumumab monotherapy: long-term insights from the CENTAURUS trial in high-risk smoldering multiple myeloma
Translational Cancer Research
2026;
15
(5)
:368
.
(30 May 2026)
Epcoritamab plus gemcitabine and oxaliplatin in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma: how should this regimen be positioned in current treatment algorithms?
Translational Cancer Research
2026;
15
(5)
:369
.
(30 May 2026)
Original Article
The anti-migratory effect of curcumin in colorectal cancer involves IKKβ/NF-κB/Snail-mediated EMT inhibition
Translational Cancer Research
2026;
15
(5)
:370
.
(30 May 2026)
Comparative efficacy and safety of systemic therapies in transplant-eligible and ineligible relapsed/refractory large B-cell lymphoma: a Bayesian network meta-analysis
Translational Cancer Research
2026;
15
(5)
:371
.
(30 May 2026)
Advancing the understanding of tumor microenvironment through medical imaging based on bibliometric analysis
Translational Cancer Research
2026;
15
(5)
:372
.
(30 May 2026)
TRIM37 interacts with PTEN to promote progression of hepatocellular carcinoma cells by modulating AKT/GSK-3β/β-Catenin pathway
Translational Cancer Research
2026;
15
(5)
:373
.
(30 May 2026)
Immune-driven induction of miR-501-5p by IL-17A enhances colorectal cancer progression
Translational Cancer Research
2026;
15
(5)
:374
.
(30 May 2026)
A prognostic model for head and neck squamous cell carcinoma based on eosinophil extracellular trap related genes
Translational Cancer Research
2026;
15
(5)
:375
.
(30 May 2026)
Targeting EHMT2 inhibition in glioblastoma: effects on tumor progression and STAT3 signaling
Translational Cancer Research
2026;
15
(5)
:376
.
(30 May 2026)
Individual and combined effects of marital status, household income, and residence on cancer management and survival in primary bone cancer: a SEER-based retrospective cohort study
Translational Cancer Research
2026;
15
(5)
:377
.
(30 May 2026)
A network pharmacology and molecular docking approach to investigate the anticancer mechanism of baicalin against melanoma through induction of apoptosis via EGFR-mediated PI3K/AKT pathway
Translational Cancer Research
2026;
15
(5)
:378
.
(30 May 2026)
The prognostic predictive value of monocyte to high-density lipoprotein cholesterol ratio in HR+/HER− breast cancer patients
Translational Cancer Research
2026;
15
(5)
:379
.
(30 May 2026)
Identification of chondroitin polymerizing factor as a biomarker for predicting immunotherapy response in breast cancer: a bioinformatics analysis of tumor microenvironment
Translational Cancer Research
2026;
15
(5)
:380
.
(30 May 2026)
Comprehensive genomics and functional analyses identify SMARCAL1 as a key oncogenic regulator in lung adenocarcinoma
Translational Cancer Research
2026;
15
(5)
:381
.
(30 May 2026)
The flavonoid astragalin induces apoptosis in lung adenocarcinoma and correlates with a prognostic cell cycle gene signature associated with PANoptosis
Translational Cancer Research
2026;
15
(5)
:382
.
(30 May 2026)
T4bN0 colon cancer shows worse survival than T1–2N1 disease: a multicenter real-world study in China
Translational Cancer Research
2026;
15
(5)
:383
.
(30 May 2026)
Development of a prognostic nomogram for colorectal cancer with peritoneal metastasis: a SEER database analysis
Translational Cancer Research
2026;
15
(5)
:384
.
(30 May 2026)
Construction and testing of a nomogram for patients with pancreatic signet-ring cell carcinoma and analysis of treatment-related survival differences: a study based on the Surveillance, Epidemiology, and End Results (SEER) database
Translational Cancer Research
2026;
15
(5)
:385
.
(30 May 2026)
WT1-AS acts as a tumor suppressor in cervical cancer via OSR2-mediated transcriptional activation
Translational Cancer Research
2026;
15
(5)
:386
.
(30 May 2026)
Prognostic significance and pathological correlation analysis of DKK4 in colorectal cancer
Translational Cancer Research
2026;
15
(5)
:387
.
(30 May 2026)
Comparison of 5-year survival rates and prognostic factors between adenoid cystic carcinoma and squamous cell carcinoma of the maxillary sinus: a SEER database analysis
Translational Cancer Research
2026;
15
(5)
:388
.
(30 May 2026)
A bibliometric analysis of global research in cervical cancer radiotherapy (2015–2024): trends, hotspots, and future directions
Translational Cancer Research
2026;
15
(5)
:389
.
(30 May 2026)
Identifying and validating of prognostic genes associated with myeloid cell differentiation in cervical cancer: development of a risk model based on single-cell RNA sequencing combined with bulk RNA sequencing data
Translational Cancer Research
2026;
15
(5)
:390
.
(30 May 2026)
Efficacy and safety of National Centralized Drug Procurement-procured versus non-National Centralized Drug Procurement oxaliplatin in unresectable or metastatic pancreatic cancer: a retrospective cohort study
Translational Cancer Research
2026;
15
(5)
:391
.
(30 May 2026)
COL10A1 overexpression potentially contributes to poor outcomes in breast cancer via autophagy and vasculogenic mimicry
Translational Cancer Research
2026;
15
(5)
:392
.
(30 May 2026)
Development and validation of prognostic nomograms for patients with cervical cancer and liver metastasis: a SEER-based study
Translational Cancer Research
2026;
15
(5)
:393
.
(30 May 2026)
Micropeptide colorectal neoplasia differentially expressed (CRNDE) 84aa encoded by CRNDE elicits a T-cell immune response to breast cancer
Translational Cancer Research
2026;
15
(5)
:394
.
(30 May 2026)
SPDEF downregulation promotes tumor aggressiveness and poor prognosis in triple-negative breast cancer
Translational Cancer Research
2026;
15
(5)
:395
.
(30 May 2026)
Identification of prognostic immune-related genes and evaluation of chemotherapy and immunotherapy responses in pancreatic cancer
Translational Cancer Research
2026;
15
(5)
:396
.
(30 May 2026)
LncRNA SOX21-AS1 is associated with poor prognosis and immunomodulation in glioblastoma
Translational Cancer Research
2026;
15
(5)
:397
.
(30 May 2026)
Hyperplasia suppressor gene inhibits the progression of malignant meningioma via the Wnt/β-catenin signaling pathway
Translational Cancer Research
2026;
15
(5)
:398
.
(30 May 2026)
Predictive modelling of duodenal stump leakage after gastric cancer and long-term oncological outcomes
Translational Cancer Research
2026;
15
(5)
:399
.
(30 May 2026)
A disulfidptosis-related lncRNA prognostic model identifies MALINC1 as a regulator of platinum drug sensitivity in colon adenocarcinoma
Translational Cancer Research
2026;
15
(5)
:400
.
(30 May 2026)
Periostin promotes papillary thyroid carcinoma progression by modulating mTOR/AKT pathway
Translational Cancer Research
2026;
15
(5)
:401
.
(30 May 2026)
Association of serum vitamins and carotenoids with breast cancer status among adult women in NHANES 2017–2018: a cross-sectional study
Translational Cancer Research
2026;
15
(5)
:402
.
(30 May 2026)
Efficacy and safety of antibody-drug conjugates for HR+/HER2-low advanced breast cancer: a systematic review with Bayesian network meta-analysis and real-world study
Translational Cancer Research
2026;
15
(5)
:403
.
(30 May 2026)
Identification of protein lysine lactylation and potential targets in esophageal squamous cell carcinoma
Translational Cancer Research
2026;
15
(5)
:404
.
(30 May 2026)
Beyond traditional survival estimates: conditional survival and individualized prognosis in primary breast lymphoma
Translational Cancer Research
2026;
15
(5)
:405
.
(30 May 2026)
Unveiling LAIR1: a prognostic biomarker associated with gastric cancer progression and metastasis
Translational Cancer Research
2026;
15
(5)
:406
.
(30 May 2026)
Comprehensive analysis to develop a stromal senescence-associated gene signature for predicting hepatocellular carcinoma
Translational Cancer Research
2026;
15
(5)
:407
.
(30 May 2026)
Epidemiology and prognostic factors of acute erythroid leukemia
Translational Cancer Research
2026;
15
(5)
:408
.
(30 May 2026)
Multi-algorithm machine learning combined with in silico gene knockout reveals the diagnostic value and functional regulatory networks of ferroptosis-related genes in gastric cancer
Translational Cancer Research
2026;
15
(5)
:409
.
(30 May 2026)
Parimifasor elicits broad-spectrum antitumor effects by suppressing the expression of oncogenic genes
Translational Cancer Research
2026;
15
(5)
:410
.
(30 May 2026)
YTHDF1 enhances ACSL3 translation in an m6A-dependent manner to regulate lipid metabolism and colorectal cancer progression
Translational Cancer Research
2026;
15
(5)
:411
.
(30 May 2026)
NCOA4-driven ferritinophagy and GSH reprogramming underlie maslinic acid-induced ferroptosis and autophagy in breast cancer
Translational Cancer Research
2026;
15
(5)
:412
.
(30 May 2026)
Liquid-liquid phase separation-related gene signature characterizes prognostic subtypes and therapeutic sensitivities in gastric cancer
Translational Cancer Research
2026;
15
(5)
:413
.
(30 May 2026)
Role of PDGFA expression in the prognosis of head and neck squamous cell carcinoma: construction of prognostic nomogram and functional mechanism exploration
Translational Cancer Research
2026;
15
(5)
:414
.
(30 May 2026)
Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating the NF-κB-MMP-2/MMP-9 signaling pathway
Translational Cancer Research
2026;
15
(5)
:415
.
(30 May 2026)
Personalized survival prediction in pediatric glioblastoma using a machine learning-powered web tool
Translational Cancer Research
2026;
15
(5)
:416
.
(30 May 2026)
Single-cell analysis identifies a tumor-specific T-cell metabolic signature: prognostic model and association with immunosuppressive microenvironment in ovarian cancer
Translational Cancer Research
2026;
15
(5)
:417
.
(30 May 2026)
Carcinogenic role of ESCO2 in cholangiocarcinoma: integration of bioinformatics analysis and experimental validation
Translational Cancer Research
2026;
15
(5)
:418
.
(30 May 2026)
A P-body-related risk score predicts prognosis and immune microenvironment in lung adenocarcinoma
Translational Cancer Research
2026;
15
(5)
:419
.
(30 May 2026)
Development and validation of nomograms for predicting overall survival and cancer-specific survival in female gastric signet-ring cell carcinoma: a SEER database analysis
Translational Cancer Research
2026;
15
(5)
:420
.
(30 May 2026)
Integrative single-cell and bulk transcriptomics identify an ALK-associated three-gene signature predicting neuroblastoma outcomes
Translational Cancer Research
2026;
15
(5)
:421
.
(30 May 2026)
Utidelone exhibits favorable responses in refractory patients with advanced breast cancer
Translational Cancer Research
2026;
15
(5)
:422
.
(30 May 2026)
Phagocytic remodeling in CD74High tumor-associated macrophages during brain metastasis of lung adenocarcinoma
Translational Cancer Research
2026;
15
(5)
:423
.
(30 May 2026)
Risk factors for cerebrospinal fluid leakage after spinal tumor surgery: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(5)
:424
.
(30 May 2026)
Cation homeostasis-related prognostic genes uncovered by transcriptomic analysis in breast cancer
Translational Cancer Research
2026;
15
(5)
:425
.
(30 May 2026)
Integrated transcriptomics identifies HIF1A and GSTP1 as biomarkers for cutaneous squamous cell carcinoma
Translational Cancer Research
2026;
15
(5)
:426
.
(30 May 2026)
Integrating innovative multiomics and machine learning strategies for prognostic biomarker discovery in hepatocellular carcinoma: guiding personalized treatment strategies with single-cell analysis
Translational Cancer Research
2026;
15
(5)
:427
.
(30 May 2026)
Identification and validation of tumor microenvironment remodeling markers associated with prognosis in differentiated thyroid cancer
Translational Cancer Research
2026;
15
(5)
:428
.
(30 May 2026)
Prognostic value and potential upstream regulator of Schwann cells in esophageal squamous cell carcinoma
Translational Cancer Research
2026;
15
(5)
:429
.
(30 May 2026)
Development and internal validation of a nomogram based on HER2 status for predicting pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
Translational Cancer Research
2026;
15
(5)
:430
.
(30 May 2026)
Circadian-immune-related gene signature for lung squamous cell carcinoma: machine learning and multi-omics analysis
Translational Cancer Research
2026;
15
(5)
:431
.
(30 May 2026)
Comprehensive analysis of prognostic biomarkers for immunotherapy response in patients with advanced malignant melanoma
Translational Cancer Research
2026;
15
(5)
:432
.
(30 May 2026)
Review Article
Mogamulizumab for adult T-cell leukemia/lymphoma: a literature review
Translational Cancer Research
2026;
15
(5)
:433
.
(30 May 2026)
Artificial intelligence in radiation treatment planning: a narrative review from automation to clinical decision support
Translational Cancer Research
2026;
15
(5)
:434
.
(30 May 2026)
Apoptosis signaling and cancer targeted therapy: from bench to bespoke
Translational Cancer Research
2026;
15
(5)
:435
.
(30 May 2026)
The research progress of gastric cancer vaccines: a narrative review
Translational Cancer Research
2026;
15
(5)
:436
.
(30 May 2026)
Neuro-glioma activity-dependent growth mechanisms: an actionable circuit from NLGN3-ADAM10 to AMPA synapses
Translational Cancer Research
2026;
15
(5)
:437
.
(30 May 2026)
Exosomal miRNA as a biomarker for diagnosis and prognosis, and a new target for regulating treatment resistance in DLBCL: a research progress narrative review
Translational Cancer Research
2026;
15
(5)
:438
.
(30 May 2026)
Erratum
Erratum: Development and validation of a machine learning model for predicting early death in metastatic pancreatic ductal adenocarcinoma: a study based on the SEER database
Translational Cancer Research
2026;
15
(5)
:439
.
(30 May 2026)
